Event Panel Schedule


Zoom #77 [Zoom]
Eval­u­at­ing the vari­ous paths to the public mar­kets IPOs, SPACs and Be­yond
Webcast
922c3ff0043dc917081ad15b5ed0342a_77335e84eab89a9defa9f8bcd24b9484_120_120
Credit Suisse
Lorenzo Paoletti, Managing Director / Credit Suisse
Mr. Lorenzo Paoletti is a Managing Director at Credit Suisse in the Investment Banking and Capital Markets division, based in New York City. He is responsible for covering the Biotech sector. Lorenzo joined Credit Suisse in November 2019 from The…

Cdc4f64a319b22fca557e551e2937729_f221feedb55d50e9edd4b675fbf0ab34_120_120
Credit Suisse
John F. Hoffman, Managing Director - Life Sciences ECM team / Credit Suisse
John Hoffman is a Managing Director in the Life Sciences Equity Capital Markets group at Credit Suisse and is responsible for leading the firm’s capital raising efforts in the Life Sciences sector. John’s product focus includes IPOs, follow-ons…

Ee8b4c071976881506c2f403c7265b3a_b3b0eba52286fa0755e691ccd904e266_120_120
Credit Suisse
Michael Allwin, Director / Credit Suisse
Michael Allwin is a Director at Credit Suisse in the Investment Banking and Capital Markets division, based in New York. He recently joined Credit Suisse towards the end of 2020 with a focus on Investment Banking coverage of the Biotech sector. In…

8126ba91a5183d904e6c7dc12128a52c_64db7a1dbb5aef38d31f2497e811efb3_120_120
Bain Capital Life Sciences
Jeffrey Schwartz, Managing Director / Bain Capital Life Sciences
Jeffrey Schwartz joined Bain Capital in 2004 and is a Managing Director. Prior to his current role, he was a member of Bain Capital’s Private Equity team, where he focused on healthcare investments. Prior to joining Bain Capital, Mr. Schwartz…

258ccfc0c4e94cc613c834e84f4dc6e3_5be238f2ad2ca19de4dc900442ac6049_120_120
Cooley LLP
Peter Byrne, Special Counsel / Cooley LLP
Peter Byrne represents both issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, secondary and follow-on offerings, debt offerings, debt exchange offers and tender offers and…

7243aaab96a8860be70914e198bc1778_5b2c5225d955c22e61ecb17669cc94e3_120_120
Solebury Capital
John Haynor, Managing Director / Solebury Capital
John Haynor is a Managing Director at Solebury Capital where he focuses on the healthcare sector. Before joining Solebury in 2019, John worked in equity capital markets for 15 years most recently as a Managing Director at Jefferies. Prior to…

TBA
Down to the Wire: Down to the Wire - With Large Caps In­creas­ing­ly Snap­ping Up Biotechs Days Be­fore IPO, How to Po­si­tion for a Range of Out­comes in the IPO Pro­cess
Webcast
03ff79ee56ca1914211d3d269c361e1f_c4acb0dfcdbb0ca20f56b6723b1e493b_120_120
Credit Suisse
Jason Jun, Director / Credit Suisse
Jason Jun is a Director at Credit Suisse in the Healthcare Investment Banking Group specializing in life sciences, based in New York. Jason has over 13 years of experience in life sciences, and since joining Credit Suisse in 2013 he has helped raise…

413d0a0e67acb41e0dfe5ebbeddf5376_bad7b6e7798415ccd3d79a2d02ad57eb_120_120
Credit Suisse
Glenn Rewick, Managing Director, Healthcare M&A / Credit Suisse
Glenn Rewick is a Managing Director in the Healthcare M&A group at Credit Suisse with over 20 years of experience. Over the course of his career Glenn has advised on transactions representing more than $75bn in deal value, including among others…

2702a4410c63e69918f90e14b6a0581c_fd626a6b12a021b1e6ad25d06e88b077_120_120
Credit Suisse
Maneet Singh, Managing Director, M&A / Credit Suisse
Maneet Singh is a Managing Director in the Mergers & Acquisitions Group at Credit Suisse. Maneet is seasoned M&A and strategy professional with significant experience in Life Sciences. He has successfully led over $200 billion of announced…

4bd786b96f445454f9b3ab2483e189a6_78b62c441b4d1a0cd6d467ab7908a2a3_120_120
Credit Suisse
NIkhil Goel, Director / Credit Suisse
Nikhil Goel is a Senior Director in the Healthcare M&A group at Credit Suisse covering life sciences sector exclusively for the last 5 years. Nikhil has ~10 years of Healthcare investment banking experience executing wide variety of deals…

247bcbaec292a536f91c822cc524f0c0_6f5586a9ecbb73976fc55566599781df_120_120
Credit Suisse
Sumit Khedekar, Managing Director / Credit Suisse
Sumit Khedekar is Americas Head of Healthcare for Credit Suisse, based in New York. He is responsible for covering pharmaceutical and biotechnology companies. He has worked on $200B of advisory transactions for multiple large biopharmaceutical and…

E501d8075937a6a7e95c9151c1cc9178_d69ad5d4becc6f130bdd4ca9862e3d2f_120_120
Cooley LLP
Michal Berkner, Partner / Cooley LLP
Michal Berkner leads cross-border mergers and acquisitions, advising tech and life sciences companies in game-changing M&A, including SPACs, reverse mergers, negotiated and unsolicited transactions and joint ventures. Her clients include…

8ef01fe922abb27eb124888fecea78cd_c779a95df84ab01ebc57540ea4b0a5f8_120_120
Solebury Trout
Michael Levitan, Managing Director / Solebury Trout
Michael Levitan is a Managing Director based in New York. Since joining the firm in 2007, Michael has worked on a wide variety of investor relations, financing and M&A advisory engagements. Michael has over 20 years of experience in healthcare…
Export to Excel